Carmen Fucile Francesca Mattioli Valeria Marini Massimo Gregori Aurelio Sonzogni Antonietta Martelli Natalia Maximova
10.2147/TCRM.S170761
Ther Clin Risk Manag
2018 Sep 7;14:1649-1655.
adverse events allo-hsct allogeneic hematopoietic stem cell transplantation deferasirox ductopenia pediatric therapeutic drug monitoring
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30237719/
PMC6136408
30237719
What is known about deferasirox chelation therapy in pediatric HSCT recipients: two case reports of metabolic acidosis
2018